
### [NCIT:C3512](http://purl.obolibrary.org/obo/NCIT_C3512)
**Label:** Lung Adenocarcinoma

**Subclasses:** [NCIT:C8759](http://purl.obolibrary.org/obo/NCIT_C8759) (Stage I Lung Adenocarcinoma AJCC v7), [NCIT:C5649](http://purl.obolibrary.org/obo/NCIT_C5649) (Acinar Lung Adenocarcinoma), [NCIT:C8757](http://purl.obolibrary.org/obo/NCIT_C8757) (Recurrent Lung Adenocarcinoma), [NCIT:C8758](http://purl.obolibrary.org/obo/NCIT_C8758) (Stage 0 Lung Adenocarcinoma AJCC v6 and v7), [NCIT:C136710](http://purl.obolibrary.org/obo/NCIT_C136710) (Lung Enteric Adenocarcinoma), [NCIT:C5650](http://purl.obolibrary.org/obo/NCIT_C5650) (Papillary Lung Adenocarcinoma), [NCIT:C5651](http://purl.obolibrary.org/obo/NCIT_C5651) (Solid Lung Adenocarcinoma), [NCIT:C8762](http://purl.obolibrary.org/obo/NCIT_C8762) (Stage IV Lung Adenocarcinoma AJCC v7), [NCIT:C136486](http://purl.obolibrary.org/obo/NCIT_C136486) (Lung Adenocarcinoma In Situ), [NCIT:C7268](http://purl.obolibrary.org/obo/NCIT_C7268) (Minimally Invasive Mucinous Lung Adenocarcinoma), [NCIT:C136490](http://purl.obolibrary.org/obo/NCIT_C136490) (Lung Adenocarcinoma by AJCC v7 Stage), [NCIT:C8760](http://purl.obolibrary.org/obo/NCIT_C8760) (Stage II Lung Adenocarcinoma AJCC v7), [NCIT:C45512](http://purl.obolibrary.org/obo/NCIT_C45512) (Lung Colloid Adenocarcinoma), [NCIT:C8761](http://purl.obolibrary.org/obo/NCIT_C8761) (Stage III Lung Adenocarcinoma AJCC v7), [NCIT:C45509](http://purl.obolibrary.org/obo/NCIT_C45509) (Fetal Lung Adenocarcinoma), [NCIT:C2923](http://purl.obolibrary.org/obo/NCIT_C2923) (Minimally Invasive Lung Adenocarcinoma), [NCIT:C136716](http://purl.obolibrary.org/obo/NCIT_C136716) (Non-Mucinous Lung Adenocarcinoma In Situ), [NCIT:C123160](http://purl.obolibrary.org/obo/NCIT_C123160) (Lepidic Predominant Adenocarcinoma), [NCIT:C136717](http://purl.obolibrary.org/obo/NCIT_C136717) (Mucinous Lung Adenocarcinoma In Situ), 

**Class expressions from DL-Learner:**

- Thing 54.77%
- [NCIT:C99724](http://purl.obolibrary.org/obo/NCIT_C99724) (EML4/ALK Fusion Gene) 52.27%
- [NCIT:C54690](http://purl.obolibrary.org/obo/NCIT_C54690) (Mucinous Tall Columnar Adenocarcinoma Cell) 52.27%
- [NCIT:C45566](http://purl.obolibrary.org/obo/NCIT_C45566) (Gain of Chromosome 3q24-qter) 52.27%
- [NCIT:C38184](http://purl.obolibrary.org/obo/NCIT_C38184) (ALK Gene) 52.27%
- [NCIT:C36856](http://purl.obolibrary.org/obo/NCIT_C36856) (Mucin-Producing Adenocarcinoma Cell) 52.27%
- [NCIT:C36695](http://purl.obolibrary.org/obo/NCIT_C36695) (LKB1 Gene Inactivation) 52.27%
- [NCIT:C36667](http://purl.obolibrary.org/obo/NCIT_C36667) (Loss of Chromosome 4q) 52.27%
- [NCIT:C36665](http://purl.obolibrary.org/obo/NCIT_C36665) (KRAS Gene Amplification) 52.27%
- [NCIT:C36659](http://purl.obolibrary.org/obo/NCIT_C36659) (CTNNB1 Gene Mutation) 52.27%
- [NCIT:C36599](http://purl.obolibrary.org/obo/NCIT_C36599) (Loss of Chromosome Y) 52.27%
- [NCIT:C36584](http://purl.obolibrary.org/obo/NCIT_C36584) (Loss of Chromosome 9) 52.27%
- [NCIT:C36583](http://purl.obolibrary.org/obo/NCIT_C36583) (Loss of Chromosome 6q) 52.27%
- [NCIT:C36503](http://purl.obolibrary.org/obo/NCIT_C36503) (Loss of Chromosome 8p) 52.27%
- [NCIT:C36497](http://purl.obolibrary.org/obo/NCIT_C36497) (Loss of Chromosome 13q) 52.27%


